CD8A and neoplasm: B16ova tumor-bearing mice that received Ly6Chi CD8+ T cells displayed substantially delayed tumor growth compared to the untreated group and the group that received adoptive cell transfer of the Ly6Clo CD8+ T cells (Figure 1C).